Fukumoto W, Okamura S, Tamai M, Arima J, et al. Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplification. BMC Cancer 2024;24:1333.
PMID: 39472827